Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Desperate people creating doubt with a reverse split headings

in a R/S?

If so I will vote a loud and clear NO.

400 Million shares on the Nasdaq is NOT too many shares.

We will easily trade at $10 or $20  or MORE with the amount of companies that will be paying us over the next 8 years + a two year look back.

No debt

Low overhead

Cash Cow

Just my 2 cents for NOW!

GLTA

Deb

Share
New Message
Please login to post a reply